These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 17556788

  • 1. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
    Tran YB, Frial T, Miller PS.
    Can J Clin Pharmacol; 2007; 14(2):e205-14. PubMed ID: 17556788
    [Abstract] [Full Text] [Related]

  • 2. Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial.
    Hirsch M, O'Donnell JC, Jones P.
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):18-28. PubMed ID: 15703502
    [Abstract] [Full Text] [Related]

  • 3. Cost effectiveness of rosuvastatin in treating patients to low-density lipoprotein cholesterol goals compared with atorvastatin, pravastatin, and simvastatin (a US Analysis of the STELLAR Trial).
    Miller PS, Smith DG, Jones P.
    Am J Cardiol; 2005 Jun 01; 95(11):1314-9. PubMed ID: 15904635
    [Abstract] [Full Text] [Related]

  • 4. Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals.
    Hirsch M, O'donnell J, Olsson A.
    Int J Cardiol; 2005 Oct 10; 104(3):251-6. PubMed ID: 16186052
    [Abstract] [Full Text] [Related]

  • 5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 10; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective.
    Costa-Scharplatz M, Ramanathan K, Frial T, Beamer B, Gandhi S.
    Clin Ther; 2008 Jul 10; 30(7):1345-57. PubMed ID: 18691996
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.
    Ohsfeldt RL, Gandhi SK, Fox KM, Stacy TA, McKenney JM.
    Am J Manag Care; 2006 Nov 10; 12(15 Suppl):S412-23. PubMed ID: 17112329
    [Abstract] [Full Text] [Related]

  • 8. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
    Cobos A, Jovell AJ, García-Altés A, García-Closas R, Serra-Majem L.
    Clin Ther; 1999 Nov 10; 21(11):1924-36. PubMed ID: 10890264
    [Abstract] [Full Text] [Related]

  • 9. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH.
    Clin Ther; 2007 Nov 10; 29(11):2385-94. PubMed ID: 18158079
    [Abstract] [Full Text] [Related]

  • 10. Cost-efficacy analysis of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors based on results of the STELLAR trial: clinical implications for therapeutic selection.
    Chong PH, Varner D.
    Pharmacotherapy; 2005 Feb 10; 25(2):270-8. PubMed ID: 15767241
    [Abstract] [Full Text] [Related]

  • 11. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
    Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP.
    Expert Opin Pharmacother; 2008 Apr 10; 9(5):669-76. PubMed ID: 18345946
    [Abstract] [Full Text] [Related]

  • 12. A cost-effectiveness model of alternative statins to achieve target LDL-cholesterol levels.
    Maclaine GD, Patel H.
    Int J Clin Pract; 2001 May 10; 55(4):243-9. PubMed ID: 11406909
    [Abstract] [Full Text] [Related]

  • 13. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 10; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM, Jones PH, Adamczyk MA, Cain VA, Bryzinski BS, Blasetto JW, STELLAR Study Group.
    Curr Med Res Opin; 2003 Jul 10; 19(8):689-98. PubMed ID: 14687438
    [Abstract] [Full Text] [Related]

  • 15. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
    Fox KM, Gandhi SK, Ohsfeldt RL, Davidson MH.
    Am J Manag Care; 2007 Dec 10; 13 Suppl 10():S270-5. PubMed ID: 18095777
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD, Rattinger GB, Kuznik A, Koren MJ.
    Clin Ther; 2008 Dec 10; 30 Pt 2():2204-16. PubMed ID: 19281915
    [Abstract] [Full Text] [Related]

  • 17. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M, DISCOVERY PENTA investigators.
    Curr Med Res Opin; 2005 Aug 10; 21(8):1307-15. PubMed ID: 16083541
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective.
    Benner JS, Smith TW, Klingman D, Tierce JC, Mullins CD, Pethick N, O'Donnell JC.
    Value Health; 2005 Aug 10; 8(6):618-28. PubMed ID: 16283862
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Bays HE.
    Curr Med Res Opin; 2007 Sep 10; 23(9):2125-33. PubMed ID: 17655813
    [Abstract] [Full Text] [Related]

  • 20. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
    Schuster H, Barter PJ, Stender S, Cheung RC, Bonnet J, Morrell JM, Watkins C, Kallend D, Raza A, Effective Reductions in Cholesterol Using Rosuvastatin Therapy I study group.
    Am Heart J; 2004 Apr 10; 147(4):705-13. PubMed ID: 15077101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.